{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T16:42:40Z","timestamp":1790613760257,"version":"4.1.0"},"reference-count":44,"publisher":"BMJ","issue":"8","license":[{"start":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T00:00:00Z","timestamp":1788134400000},"content-version":"unspecified","delay-in-days":30,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000865","name":"Bill and Melinda Gates Foundation","doi-asserted-by":"publisher","award":["INV-034281 (OPP1157270 \/ INV-009125)"],"award-info":[{"award-number":["INV-034281 (OPP1157270 \/ INV-009125)"]}],"id":[{"id":"10.13039\/100000865","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100023693","name":"Vaccine Impact Modelling Consortium","doi-asserted-by":"publisher","award":["INV-034281"],"award-info":[{"award-number":["INV-034281"]}],"id":[{"id":"10.13039\/501100023693","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100023693","name":"Vaccine Impact Modelling Consortium","doi-asserted-by":"publisher","award":["OPP1157270 \/ INV-009125"],"award-info":[{"award-number":["OPP1157270 \/ INV-009125"]}],"id":[{"id":"10.13039\/501100023693","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Glob Health"],"accepted":{"date-parts":[[2026,8,11]]},"published-print":{"date-parts":[[2026,8]]},"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Human papillomavirus (HPV) is a leading cause of both cervical and non-cervical cancers, including anal, oropharyngeal, vaginal and vulvar cancers. While most HPV vaccination impact assessments have focused on preventing cervical cancer among women, the broader benefits of vaccination against other HPV-attributable cancers in low- and middle-income countries (LMICs) remain less explored.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We used a static cohort model to assess the potential health impact of bivalent HPV vaccination on HPV-attributable female non-cervical cancers in 117 LMICs from 2030 to 2100. The model incorporated country-specific data on cancer mortality, HPV type distribution, demographic projections and vaccine coverage. Sensitivity analyses were performed to account for uncertainties in cancer incidence, cancer mortality and HPV type distribution.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Our projections suggest that HPV vaccination could contribute to prevention of approximately five\u200990\u2009000 cases of anal, 880\u2009000 cases of oropharyngeal, 1.27 million cases of vaginal and 2.18 million cases of vulvar cancers over the analytic period. In total, 3.02 million deaths from these non-cervical cancers among women could be averted by 2100. The African region is expected to see the largest relative reductions in both cases and deaths while the European region showed the smallest gains. By the end of the century, 58 countries are projected to reach at least a 25% reduction in anal cancer mortality compared with just 25 countries for oropharyngeal cancer. These findings reflect substantial regional disparities in both burden and vaccination impact.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>HPV vaccination holds considerable promise in reducing the burden of non-cervical cancers among women in LMICs, especially in regions with high incidence and limited access to care. Recognising and harnessing these broader benefits can strengthen the public health case for scaling up vaccine access, implementing region-specific strategies and investing in equitable healthcare systems to decrease global disparities.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/bmjgh-2025-021127","type":"journal-article","created":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T11:20:14Z","timestamp":1788175214000},"page":"e021127","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":1,"title":["Projections of human papillomavirus (HPV) vaccination impact on non-cervical cancer outcomes among women in 117 low- and middle-income countries: a modelling study"],"prefix":"10.1136","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0009-0005-4184-2911","authenticated-orcid":false,"given":"Aarushi","family":"Tuli","sequence":"first","affiliation":[{"name":"Department of Global Health, Boston University School of Public Health, Boston, Massachusetts, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Jit","sequence":"additional","affiliation":[{"name":"Department of Global and Environmental Health, New York University School of Global Public Health, New York, New York, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0563-1576","authenticated-orcid":false,"given":"Kaja","family":"Abbas","sequence":"additional","affiliation":[{"name":"Department of Infectious Disease Epidemiology and Dynamics, London School of Hygiene & Tropical Medicine, London, UK"},{"name":"School of Tropical Medicine and Global Health, Nagasaki University, Nagasaki, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8467-1324","authenticated-orcid":false,"given":"Allison","family":"Portnoy","sequence":"additional","affiliation":[{"name":"Department of Global Health, Boston University School of Public Health, Boston, Massachusetts, USA"},{"name":"Center for Health Decision Science, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2026,8,31]]},"reference":[{"key":"2026083104200589000_11.8.e021127.1","unstructured":"World Health Organization . Human papillomavirus and cancer. 2024. Available: https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/human-papilloma-virus-and-cancer"},{"key":"2026083104200589000_11.8.e021127.2","unstructured":"National Cancer Institute . HPV and cancer. 2025. Available: https:\/\/www.cancer.gov\/about-cancer\/causes-prevention\/risk\/infectious-agents\/hpv-and-cancer"},{"key":"2026083104200589000_11.8.e021127.3","unstructured":"Iarc.fr . Cancer today. 2025. Available: https:\/\/gco.iarc.fr\/today\/en\/dataviz\/tables?mode=cancer&group_populations=1&multiple_populations=1&sexes=2&populations=989&group_crc=0&cancers_h=10_3_22_21&types=0&cancers= [Accessed 19 Jun 2025]."},{"key":"2026083104200589000_11.8.e021127.4","unstructured":"National Cancer Institute . Human Papillomavirus (HPV) vaccines. 2021. Available: https:\/\/www.cancer.gov\/about-cancer\/causes-prevention\/risk\/infectious-agents\/hpv-vaccine-fact-sheet"},{"key":"2026083104200589000_11.8.e021127.5","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2014.06.038"},{"key":"2026083104200589000_11.8.e021127.6","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa061760"},{"key":"2026083104200589000_11.8.e021127.7","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1405044"},{"key":"2026083104200589000_11.8.e021127.8","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(20)30524-6"},{"key":"2026083104200589000_11.8.e021127.9","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)30068-4"},{"key":"2026083104200589000_11.8.e021127.10","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)30157-4"},{"key":"2026083104200589000_11.8.e021127.11","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1097\/01.ogx.0000559679.95802.ff","article-title":"Impact of Scaled up Human Papillomavirus Vaccination and Cervical Screening and the Potential for Global Elimination of Cervical Cancer in 181 Countries, 2020\u201399: A Modelling Study","volume":"74","author":"Simms","year":"2019","journal-title":"Obstet Gynecol Surv"},{"key":"2026083104200589000_11.8.e021127.12","unstructured":"WHO . Human Papillomavirus (HPV). 2022. Available: https:\/\/www.who.int\/teams\/immunization-vaccines-and-biologicals\/diseases\/human-papillomavirus-vaccines-(HPV)"},{"key":"2026083104200589000_11.8.e021127.13","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2010.09.030"},{"key":"2026083104200589000_11.8.e021127.14","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2008.04.053"},{"key":"2026083104200589000_11.8.e021127.15","unstructured":"R Core Team . R: a language and environment for statistical computing. R Foundation for Statistical Computing; 2025. Available: https:\/\/www.r-project.org\/"},{"key":"2026083104200589000_11.8.e021127.16","doi-asserted-by":"crossref","DOI":"10.1136\/bmjgh-2021-006940","article-title":"Projections of human papillomavirus (HPV) vaccination impact in Ethiopia, India, Nigeria and Pakistan: a comparative modelling study","volume":"6","author":"Portnoy","year":"2021","journal-title":"BMJ Glob Health"},{"key":"2026083104200589000_11.8.e021127.17","unstructured":"United Nations, Department of Economic and Social Affairs, Population Division . World population prospects: 2019: highlights (ST\/ESA\/SER.A\/423). United Nations Digital Library; 2019. Available: https:\/\/digitallibrary.un.org\/record\/3813698?ln=en"},{"key":"2026083104200589000_11.8.e021127.18","unstructured":"WHO methods and data sources for life tables 1990\u20132019. Global health estimates technical paper. Geneva World Health Organization; 2020. Available: https:\/\/www.who.int\/docs\/default-source\/gho-documents\/global-health-estimates\/ghe2019_life-table-methods.pdf"},{"key":"2026083104200589000_11.8.e021127.19","unstructured":"Cancer today. n.d. Available: https:\/\/gco.iarc.who.int\/today\/"},{"key":"2026083104200589000_11.8.e021127.20","unstructured":"Hamadeh N , Rompaey C , Metreau E , et al . New World Bank country classifications by income level: 2022-2023. World Bank Blogs; 2022. Available: https:\/\/blogs.worldbank.org\/en\/opendata\/new-world-bank-country-classifications-income-level-2022-2023"},{"key":"2026083104200589000_11.8.e021127.21","doi-asserted-by":"crossref","DOI":"10.1093\/jncics\/pky045","article-title":"Burden of Human Papillomavirus (HPV)-Related Cancers Attributable to HPVs 6\/11\/16\/18\/31\/33\/45\/52 and 58","volume":"2","author":"de Sanjos\u00e9","year":"2018","journal-title":"JNCI Cancer Spectr"},{"key":"2026083104200589000_11.8.e021127.22","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.30716"},{"key":"2026083104200589000_11.8.e021127.23","doi-asserted-by":"crossref","DOI":"10.1093\/jnci\/djv403","article-title":"HPV Involvement in Head and Neck Cancers: Comprehensive Assessment of Biomarkers in 3680 Patients","volume":"108","author":"Castellsagu\u00e9","year":"2016","journal-title":"J Natl Cancer Inst"},{"key":"2026083104200589000_11.8.e021127.24","unstructured":"World Health Organization, UNICEF . WHO\u2013UNICEF coverage estimates: vaccine preventable diseases, global summary reference time series, 2021. Geneva World Health Organization; 2021. Available: http:\/\/apps.who.int\/immunization_monitoring\/globalsummary\/timeseries\/tswucoveragedtp3.html"},{"key":"2026083104200589000_11.8.e021127.25","unstructured":"World Health Organization . WHO immunization data portal - all data. Immunization Data. n.d. Available: https:\/\/immunizationdata.who.int\/global?topic=&location="},{"key":"2026083104200589000_11.8.e021127.26","doi-asserted-by":"crossref","first-page":"S28","DOI":"10.1016\/j.vaccine.2023.07.033","article-title":"Modeling the impact of vaccination for the immunization Agenda 2030: Deaths averted due to vaccination against 14 pathogens in 194 countries from 2021 to 2030","volume":"42 Suppl 1","author":"Carter","year":"2024","journal-title":"Vaccine"},{"key":"2026083104200589000_11.8.e021127.27","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.67635","article-title":"Lives saved with vaccination for 10 pathogens across 112 countries in a pre-COVID-19 world","volume":"10","author":"Toor","year":"2021","journal-title":"Elife"},{"key":"2026083104200589000_11.8.e021127.28","doi-asserted-by":"crossref","first-page":"e563","DOI":"10.1016\/S2214-109X(23)00603-4","article-title":"Estimating the health effects of COVID-19-related immunisation disruptions in 112 countries during 2020-30: a modelling study","volume":"12","author":"Hartner","year":"2024","journal-title":"Lancet Glob Health"},{"key":"2026083104200589000_11.8.e021127.29","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(12)70187-1"},{"key":"2026083104200589000_11.8.e021127.30","doi-asserted-by":"publisher","DOI":"10.4161\/hv.29532"},{"key":"2026083104200589000_11.8.e021127.31","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(09)61248-4"},{"key":"2026083104200589000_11.8.e021127.32","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2012.04.108"},{"key":"2026083104200589000_11.8.e021127.33","unstructured":"Human papillomavirus and related diseases report WORLD. n.d. Available: https:\/\/hpvcentre.net\/statistics\/reports\/XWX.pdf"},{"key":"2026083104200589000_11.8.e021127.34","unstructured":"United Nations . World population prospects. 2024. Available: https:\/\/population.un.org\/wpp\/"},{"key":"2026083104200589000_11.8.e021127.35","unstructured":"Who.int . Human papillomavirus vaccine coverage in Rwanda: a population-level analysis by birth cohort. 2020. Available: https:\/\/www.iarc.who.int\/news-events\/human-papillomavirus-vaccine-coverage-in-rwanda-a-population-level-analysis-by-birth-cohort\/"},{"key":"2026083104200589000_11.8.e021127.36","doi-asserted-by":"publisher","DOI":"10.1016\/j.ypmed.2020.106399"},{"key":"2026083104200589000_11.8.e021127.37","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1097\/OLQ.0000000000001405","article-title":"Human Papillomavirus Vaccine to End Oropharyngeal Cancer. A Systematic Review and Meta-Analysis","volume":"48","author":"Tsentemeidou","year":"2021","journal-title":"Sex Transm Dis"},{"key":"2026083104200589000_11.8.e021127.38","doi-asserted-by":"crossref","DOI":"10.1093\/ije\/dyw276","article-title":"International trends in anal cancer incidence rates","volume":"dyw276","author":"Islami","year":"2016","journal-title":"Int J Epidemiol"},{"key":"2026083104200589000_11.8.e021127.39","first-page":"61","article-title":"Landscape report on the economics of integration of immunization and primary health care services in low- and middle-income countries [version 1; not peer reviewed]","volume":"6","author":"Portnoy","year":"2022","journal-title":"Gates Open Res"},{"key":"2026083104200589000_11.8.e021127.40","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2010.05.056"},{"key":"2026083104200589000_11.8.e021127.41","article-title":"Chapter 21: Modelling the impact of HPV vaccines on cervical cancer and screening programmes","volume":"24 Suppl 3","author":"Garnett","year":"2006","journal-title":"Vaccine"},{"key":"2026083104200589000_11.8.e021127.42","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.28963"},{"key":"2026083104200589000_11.8.e021127.43","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-023-02658-0"},{"key":"2026083104200589000_11.8.e021127.44","doi-asserted-by":"crossref","DOI":"10.3390\/vaccines9121413","article-title":"Human Papillomavirus Vaccine Efficacy and Effectiveness against Cancer","volume":"9","author":"Kamolratanakul","year":"2021","journal-title":"Vaccines (Basel)"}],"container-title":["BMJ Global Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjgh-2025-021127","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T11:20:21Z","timestamp":1788175221000},"score":1,"resource":{"primary":{"URL":"https:\/\/gh.bmj.com\/lookup\/doi\/10.1136\/bmjgh-2025-021127"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":44,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2026,8,31]]},"published-print":{"date-parts":[[2026,8]]}},"alternative-id":["10.1136\/bmjgh-2025-021127"],"URL":"https:\/\/doi.org\/10.1136\/bmjgh-2025-021127","relation":{},"ISSN":["2059-7908"],"issn-type":[{"value":"2059-7908","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8]]}}}